-
Je něco špatně v tomto záznamu ?
From orexin receptor agonist YNT-185 to novel antagonists with drug-like properties for the treatment of insomnia
E. Mezeiova, J. Janockova, J. Konecny, T. Kobrlova, M. Benkova, R. Dolezal, L. Prchal, J. Karasova-Zdarova, O. Soukup, J. Korabecny
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- aniliny farmakologie terapeutické užití MeSH
- benzamidy farmakologie terapeutické užití MeSH
- lidé MeSH
- molekulární struktura MeSH
- orexinové receptory terapeutické užití MeSH
- poruchy iniciace a udržování spánku farmakoterapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
YNT-185 is the first known small molecule acting as orexin 2 receptor (OX2R) agonist with implication to narcolepsy treatment, served as a template scaffold in generating a small set of seven compounds with predictive affinity to OX2R. The design of the new small molecules was driven mostly by improving physicochemical properties of the parent drug YNT-185 in parallel with in silico studies, later suggesting their favorable binding modes within the active site of OX2R. We obtained seven new potential OX2R binders that were evaluated in vitro for their CNS availability, cytotoxicity, and behavior pattern on OX2R. Out of them, 15 emerged as the most potent modulator of OX2R, which, contrary to YNT-185, displayed inverse mode of action, i.e. antagonist profile. 15 was also submitted to an in vivo experiment revealing its ability to permeate through BBB into the brain with a short half-life.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21012056
- 003
- CZ-PrNML
- 005
- 20221024102700.0
- 007
- ta
- 008
- 210420s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bioorg.2020.104179 $2 doi
- 035 __
- $a (PubMed)32891860
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Mezeiová, Eva $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic $7 xx0277560
- 245 10
- $a From orexin receptor agonist YNT-185 to novel antagonists with drug-like properties for the treatment of insomnia / $c E. Mezeiova, J. Janockova, J. Konecny, T. Kobrlova, M. Benkova, R. Dolezal, L. Prchal, J. Karasova-Zdarova, O. Soukup, J. Korabecny
- 520 9_
- $a YNT-185 is the first known small molecule acting as orexin 2 receptor (OX2R) agonist with implication to narcolepsy treatment, served as a template scaffold in generating a small set of seven compounds with predictive affinity to OX2R. The design of the new small molecules was driven mostly by improving physicochemical properties of the parent drug YNT-185 in parallel with in silico studies, later suggesting their favorable binding modes within the active site of OX2R. We obtained seven new potential OX2R binders that were evaluated in vitro for their CNS availability, cytotoxicity, and behavior pattern on OX2R. Out of them, 15 emerged as the most potent modulator of OX2R, which, contrary to YNT-185, displayed inverse mode of action, i.e. antagonist profile. 15 was also submitted to an in vivo experiment revealing its ability to permeate through BBB into the brain with a short half-life.
- 650 _2
- $a aniliny $x farmakologie $x terapeutické užití $7 D000814
- 650 _2
- $a benzamidy $x farmakologie $x terapeutické užití $7 D001549
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a orexinové receptory $x terapeutické užití $7 D064446
- 650 _2
- $a poruchy iniciace a udržování spánku $x farmakoterapie $7 D007319
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Janockova, Jana $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic
- 700 1_
- $a Konecny, Jan $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic
- 700 1_
- $a Kobrlová, Tereza, $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic $d 1991- $7 xx0277928
- 700 1_
- $a Benkova, Marketa $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic
- 700 1_
- $a Dolezal, Rafael $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic
- 700 1_
- $a Prchal, Lukas $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic
- 700 1_
- $a Karasova-Zdarova, Jana $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic
- 700 1_
- $a Soukup, Ondrej $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. Electronic address: ondrej.soukup@fnhk.cz
- 700 1_
- $a Korabecny, Jan $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. Electronic address: jan.korabecny@fnhk.cz
- 773 0_
- $w MED00000771 $t Bioorganic chemistry $x 1090-2120 $g Roč. 103, č. - (2020), s. 104179
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32891860 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20221024102658 $b ABA008
- 999 __
- $a ok $b bmc $g 1650437 $s 1132435
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 103 $c - $d 104179 $e 20200826 $i 1090-2120 $m Bioorganic chemistry $n Bioorg Chem $x MED00000771
- LZP __
- $a Pubmed-20210420
